ClinicalTrials.Veeva

Menu

The Impact of Continuous Transcutaneous CO2 (TCCO2) Monitoring in Extremely Low Birth Weight (ELBW) Infants

R

Rambam Health Care Campus

Status

Completed

Conditions

IVH- Intraventricular Hemorrhage
ELBW - Extremely Low Birth Weight Infant

Study type

Observational

Funder types

Other

Identifiers

NCT03477708
TCCO2 monitoring in ELBW

Details and patient eligibility

About

An observational study comparing outcomes of Extremely Low Birth Weight (ELBW) infants that were monitored with non-invasive Transcutaneous CO2 (TCCO2) monitor to infants that were not monitored by TCCO2 monitor.

Enrollment

166 patients

Sex

All

Ages

Under 24 hours old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ELBW infants Need of respiratory support

Exclusion criteria

  • Parental refusal IVH before study entry chromosomal abnormalities congenital central nervous system (CNS) abnormalities

Trial design

166 participants in 2 patient groups

Study group
Description:
TCCO2 monitoring
Control group
Description:
Routine monitoring

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems